0001225208-22-000113.txt : 20220103 0001225208-22-000113.hdr.sgml : 20220103 20220103165139 ACCESSION NUMBER: 0001225208-22-000113 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220101 FILED AS OF DATE: 20220103 DATE AS OF CHANGE: 20220103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meredith Ian T CENTRAL INDEX KEY: 0001693920 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 22502750 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2022-01-01 0000885725 BOSTON SCIENTIFIC CORP BSX 0001693920 Meredith Ian T 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP Global Chief Med Officer Common Stock 2022-01-01 4 M 0 3649.0000 0.0000 A 29892.0000 D Common Stock 2022-01-01 4 F 0 1265.0000 42.4800 D 28627.0000 D Performance Share Units 2022-01-01 4 M 0 3649.0000 0.0000 D 2021-12-31 2021-12-31 Common Stock 3649.0000 0.0000 D On February 21, 2019, the reporting person was awarded a target number of performance share units under the Company's 2019 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2019 adjusted free cash flow measured against its 2019 financial plan over the one-year performance period ending December 31, 2019 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2020, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2021. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. /s/ Vance R. Brown, Attorney-in-fact 2022-01-02